BioCentury
ARTICLE | Company News

Illumina, Burning Rock to develop cancer diagnostics kit

August 26, 2015 2:05 AM UTC

Illumina Inc. (NASDAQ:ILMN) and Burning Rock Biotech (Guangzhou, China) will collaborate to develop an oncology molecular diagnostics kit for the Chinese market. The kit will include Illumina's next-generation sequencing instruments and reagents, and Burning Rock's DNA preparation techniques and data analysis software.

Illumina declined to disclose financial details. Burning Rock did not respond to inquiries. ...